Cetera Investment Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,052
Closed -$204K 599
2019
Q3
$204K Sell
2,052
-284
-12% -$27K 0.02% 506
2019
Q2
$215K Buy
2,336
+122
+6% +$11.6K 0.03% 472
2019
Q1
$212K Buy
+2,214
New +$194K 0.03% 448
2018
Q4
Sell
-3,172
Closed -$283K 519
2018
Q3
$283K Buy
+3,172
New +$280K 0.04% 379
2018
Q2
Sell
-2,536
Closed -$227K 450
2018
Q1
$227K Buy
2,536
+480
+23% +$46.1K 0.04% 345
2017
Q4
$213K Sell
2,056
-680
-25% -$76.7K 0.04% 379
2017
Q3
$398K Buy
2,736
+545
+25% +$74.2K 0.09% 272
2017
Q2
$284K Buy
2,191
+120
+6% +$14.7K 0.07% 312
2017
Q1
$253K Buy
2,071
+149
+8% +$17.8K 0.07% 301
2016
Q4
$225K Hold
1,922
0.08% 288
2016
Q3
$200K Sell
1,922
-6,118
-76% -$662K 0.09% 262
2016
Q2
$793K Sell
8,040
-260
-3% -$26.9K 0.31% 100
2016
Q1
$833K Buy
8,300
+123
+2% +$12.7K 0.36% 74
2015
Q4
$978K Buy
+8,177
New +$946K 0.45% 62

Other funds holding CELG

Cetera Investment Advisers's CELG Position: Q4 2019 in Review

Cetera Investment Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,052 shares — an estimated $204K sold.

Cetera Investment Advisers first reported a position in CELG in Q4 2015 and held it in 14 quarters. The position peaked at $978K in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Cetera Investment Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Cetera Investment Advisers sold 2,052 Celgene Corp shares in Q4 2019, an estimated $204K.
  • Cetera Investment Advisers first reported a position in Celgene Corp in Q4 2015 and held it in 14 quarters.
  • Cetera Investment Advisers's Celgene Corp position peaked at $978K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Cetera Investment Advisers's 13F filing for Q4 2019, filed 10 Feb 2020.